Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative trial of metabolic parameters and cardiovascular risk in chronic hepatitis B patients treated with Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide
TCTR20220209003Phase 4Completed
- Sponsor
- Siriraj Hospital
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir disoproxil fumarate, tenofovir alafenamide in Chronic Hepatitis B (CHB), sponsored by Siriraj Hospital. Started Jul 2022; status: completed.
02
Drugs
tenofovir disoproxil fumaratetenofovir alafenamide
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on TCTR20220209003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220209003.